Skip to content
zameds

Palonosetron (Loxonext, Poltazo, Hetnoset)

Palonosetron

Hetero Drugs South Africa (Pty) Ltd

Registration

Applicant
Hetero Drugs South Africa (Pty) Ltd
Registrations
3

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Loxonext

EACH VIAL CONTAINS PALONOSETRON HYDROCHLORIDE EQUIVALENT TO PALONOSETRON 0,25 mg

Not listed54028954/5.10/0289RegisteredNot determinedNone
Poltazo

EACH VIAL CONTAINS PALONOSETRON HYDROCHLORIDE EQUIVALENT TO PALONOSETRON 0,25 mg

Not listed540290.28954/5.10/0290.289RegisteredNot determinedNone
Hetnoset

EACH VIAL CONTAINS PALONOSETRON HYDROCHLORIDE EQUIVALENT TO PALONOSETRON 0,25 mg

Not listed540291.28954/5.10/0291.289RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Netupitant

    Consolidated Schedules 06 July 2026, line 7243

  • S4: Palonosetron

    Consolidated Schedules 06 July 2026, line 7461

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C19H24N2O296.40 g/mol

(3AS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one

Drag to rotate. Structure from PubChem CID 6337614.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles